Bicarbonate

Bicarbonate

SCHEMBL410565

O.O=C(O)O.O=C(O)O.[AlH3].[CaH2].[MgH2]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
ACHE P22303 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL27684091 1.00 CA1 (0.56) CA1CA2CA9ACHEFFAR3
Bicarbonate SCHEMBL18862892 1.00
Bicarbonate SCHEMBL18862893 1.00 CA1 (0.56) CA1CA2CA9ACHEFFAR3
Bicarbonate SCHEMBL8009116 0.94
Bicarbonate SCHEMBL5557762 0.94
Bicarbonate SCHEMBL14563795 0.94
Bicarbonate SCHEMBL5015541 0.94
Bicarbonate SCHEMBL14881195 0.94 CA1 (0.62) CA1CA2CA9ACHEFFAR3
Bicarbonate SCHEMBL81418 0.94
Bicarbonate SCHEMBL28460247 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2009513512-A 2009-04-02 JP claimed
US-20050038018-A1 Mixture with antacids, sedatives; central nervous system stimulants; antiinflammatory agents; analgesics BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-02-17 US claimed
WO-2005004915-A2 COMPOSITIONS COMPRISING MELOXICAM BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-01-20 WO claimed
US-6555137-B1 For delayed release of an antacid in the stomach containing a coated antacid CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-29 US claimed
EP-1000614-A1 SUCRALFATE-CONTAINING COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-05-17 EP claimed
CN-117467166-A Method for inhibiting accumulation 旭化成株式会社 2024-01-30 CN disclosed
CN-112585192-B Cellulose powder, use thereof and tablets 旭化成株式会社 2023-11-21 CN disclosed
CN-116406260-A Solid preparation containing ibuprofen SS制药株式会社 2023-07-07 CN disclosed
EP-3880171-B1 IBUPROFEN-CONTAINING ORAL PHARMACEUTICAL FORMULATION SSP CO LTD (JP) 2023-06-07 EP disclosed
EP-3385306-B1 COMPOSITE PARTICLES INCLUDING CELLULOSE, INORGANIC COMPOUND, AND HYDROXYPROPYL CELLULOSE ASAHI CHEMICAL IND (JP) 2023-01-25 EP disclosed
WO-2022114240-A1 SOLID PREPARATION CONTAINING IBUPROFEN SSP CO., LTD. (JP) 2022-06-02 WO disclosed
EP-3989945-A1 MELOXICAM-CONTAINING GRANULATED PRODUCT SSP Co., Ltd. (JP) 2022-05-04 EP disclosed
US-20030069213-A1 ORAL PREPARATION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-10 US disclosed
CN-1280506-A Oral Preparation DAIICHI SEIYAKU CO (JP) 2001-01-17 CN disclosed
EP-1020193-A1 ORAL PREPARATION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed
EP-1000614-A1 SUCRALFATE-CONTAINING COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-05-17 EP disclosed
CN-1243004-A Enterogastric medicine for resisting activity of pyloric twining bacillus TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-02-02 CN disclosed
US-5294439-A Stabilized benzimidazole derivative and composition NIPPON CHEMIPHAR CO., LTD. (JP) 1994-03-15 US disclosed
EP-0248634-B1 STABILIZED BENZIMIDAZOLE DERIVATIVE AND COMPOSITION NIPPON CHEMIPHAR CO., LTD. (JP) 1993-07-21 EP disclosed
EP-0248634-A2 Stabilized benzimidazole derivative and composition NIPPON CHEMIPHAR CO., LTD. (JP) 1987-12-09 EP disclosed